April 2026

Johnson & Johnson to acquire Atraverse Medical ()
Heart Rhythm 2026: Electrophysiologist Mina Chung discusses CPR, PFA and much more ()
Doctors agree: There’s a lot to love about cardiology’s future ()
Women live longer after TAVR than men ()
FDA approves next-gen mitral valve from Medtronic ()
PFA's dominance and other key electrophysiology trends on display at Heart Rhythm 2026 ()
Virtual nursing staff may help save cardiology departments from burnout ()
IV fluids recalled over possible contamination—patients face risk of vascular complications ()
FDA warns public about vascular device after 3 deaths ()
How to implement AI-powered coronary plaque analysis software—and ensure you get paid ()
Abbott gains FDA clearance, CE mark approval for AI-powered imaging platform ()
New SCAI President Dawn Abbott outlines workforce training and inclusion priorities ()
Boston Scientific pacemakers recalled again—software update now available ()
Fewer stents, positive outcomes: Sirolimus-eluting balloons a safe alternative during PCI ()
Multiple GLP-1 drugs linked to lower AFib risk ()
Popular weight loss drug linked to key benefits for patients undergoing TAVR, PCI ()
Many high-risk pregnant patients still miss out on guideline-recommended care ()
‘Father of modern cardiology’ Eugene Braunwald dies at 96 ()
First bedside procedure of its kind performed by traveling clinicians on premature infant ()
Researchers use multi-modality imaging to learn more about MINOCA ()
FDA approves 2 implantable heart devices from Biotronik ()
Trump administration moves to speed up Medicare coverage for breakthrough cardiology devices ()
Heart failure experts agree: HFmrEF should not be ignored ()
From Plaque to Payment: Curious Cases, New Codes ()
When bioprosthetic mitral valves fail: Redo surgery bests transcatheter treatment after 5 years ()
Cardiologist makes ‘Magic,’ performs first procedure in US with new-look ablation catheter ()
Sirolimus- and paclitaxel-coated balloons deliver comparable 1-year PCI outcomes ()
Evolocumab reduces risk of major cardiac events in diabetic patients ()
Medtronic leads $100M investment in artery denervation company ()
How to prevent the most common complication after heart surgery ()
FDA clears next-gen hybrid system for intravascular imaging ()
Heart Rhythm 2026 to feature late-breaking EP data, hands-on training and more ()
Late-breaking PCI data challenge the 'time is muscle' paradigm ()
Weight loss pill linked to reduced risk of heart attack or stroke after FDA requested more data ()
Cardiologists now earn more than radiologists or plastic surgeons ()
Early SAVR in asymptomatic heart patients linked to long-term benefits ()
Cardiology practice launches walk-in clinic in Pennsylvania ()
Can energy drinks cause heart disease? New lawsuit says teen died from caffeine-induced cardiomyopathy ()
Another win for opportunistic screening: AI turns head CT scans into heart assessments ()
FDA approves fast-acting heart drug for children ()
New data point to LAAO as a safe alternative to long-term drug therapy ()
Long-term antidepressant use may increase risk of sudden cardiac death ()
Stereotaxis to acquire robotic PCI company Robocath for up to $45M ()
FDA links weight loss pill to ‘unexpected’ cardiovascular risks ()
PFA associated with heightened stroke risk ()
Outgoing SCAI president reflects on a busy year full of partnerships and advocacy ()
FDA clears next-gen device for left-heart access ()
Heartflow sues cardiology AI rival Cleerly over alleged patent infringement ()
More patients, fewer doctors: Demand keeps climbing as the cardiologist shortage continues ()
Stryker enters competitive IVL space with acquisition of Amplitude Vascular Systems ()
FDA shares warning about cath lab procedure kits due to risk of patient injury ()
New data highlight an unexpected link between hypercortisolism and resistant hypertension ()
FDA clears new AI model for detecting signs of cardiac amyloidosis ()
PVL after TTVR linked to much lower survival rate, fewer clinical benefits ()
SVS quality initiative gathers data to improve vascular care ()
Post-TAVR bleeding in AFib patients much less common with apixaban than rivaroxaban ()
FDA warns that certain sizing catheters should not be used due to risk of breaking ()
Medline recalls millions of devices due to safety risk—FDA threatens ‘regulatory action’ in warning letter ()
Mount Sinai announces new global center focused on heart valve disease ()
First patients treated in new PFA trial ()
New gene therapy may help protect the hearts of patients with Friedreich's ataxia ()
Long-term cardiac amyloidosis survival benefits seen in extension acoramidis trial ()
Johnson & Johnson launches faster PFA system in Europe ()
FDA clears way for IDE pivotal trial of the Topaz tricuspid valve replacement system ()
Deepak Bhatt discusses some of the most impactful trials at ACC 2026 ()
Screening and treatment for chronic kidney disease in heart disease patients needs to be expanded ()
Arizona cardiology practice paying $3.85M to resolve lawsuit after data breach ()
FDA approves another GLP-1 pill for weight loss ()
Cardiologist was fired for speaking out about racist texts, private jet misuse, lawsuit claims ()
Hospital sues cardiology practice for alleged breach of contract, ending years-long partnership ()
Impactful innovations reshape learning and technology at ACC.26 ()
Cost-related medication non-adherence declined after the Inflation Reduction Act ()
New temporary pacing system for TAVR launches in US ()
Private equity-backed cardiology practice adding new in-house smart lab powered by AI ()
AI-powered EHR alerts make a world of difference for cardiologists, heart patients ()
FDA confirms another recall for Johnson & Johnson’s Impella heart pumps ()
Key clinical takeaways from ACC.26 ()